BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11454707)

  • 21. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
    Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
    Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
    Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
    Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors.
    Toyota M; Shen L; Ohe-Toyota M; Hamilton SR; Sinicrope FA; Issa JP
    Cancer Res; 2000 Aug; 60(15):4044-8. PubMed ID: 10945606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
    Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
    Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells.
    Xia TS; Shi JP; Ding Q; Liu XA; Zhao Y; Liu YX; Xia JG; Wang S; Ding YB
    Med Oncol; 2012 Jun; 29(2):448-53. PubMed ID: 21347717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer.
    Dong SW; Ma L; Xu N; Yan HQ; Liu HY; Li YW; Zhang P
    Neoplasma; 2011; 58(1):89-95. PubMed ID: 21067271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
    Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
    Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
    Levine JJ; Stimson-Crider KM; Vertino PM
    Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of spleen tyrosine kinase expression re-activation by inhibition of DNA methylation on oncogenesis growth of gastric cancer].
    Ding YB; Xia JG; Chen GY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):523-6. PubMed ID: 17143801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic silencing of novel tumor suppressors in malignant melanoma.
    Muthusamy V; Duraisamy S; Bradbury CM; Hobbs C; Curley DP; Nelson B; Bosenberg M
    Cancer Res; 2006 Dec; 66(23):11187-93. PubMed ID: 17145863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
    Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y
    Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
    Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.